- NSE
- WOCKPHARMA
- BSE
- 532300
- ISIN
- INE049B01025
WOCKHARDT
Healthcare· Pharmaceuticals & Biotechnology· Pharmaceuticals
₹2,054.00
+₹19.40 (+0.95%)
NSE close ·
WOCKHARDT closed at ₹2,054.00 on 12 Nov 2026, up 0.95% on the day, and is up 51.01% over the past year.
Price history
Between 12 Nov 2025 and 12 Nov 2026, the closing price ranged from ₹1,100.30 to ₹2,329.70.
Price returns, excl. dividends. 3Y, 5Y and Max are annualised.
Fundamentals
- Market cap
- ₹33,376 Cr
- P/E (TTM)
- 81.4
- Industry P/E
- 35.0
- EPS (TTM)
- ₹25.23
- P/B
- 6.47
- Book value
- ₹317.43
- ROE
- 7.9%
- ROCE
- 9.1%
- Debt/equity
- 0.42
- Operating margin
- 14.7%
- Net margin
- 10.9%
- Dividend yield
- 0.00%
Market cap, P/E, P/B and yield at the 12 Nov 2026 close. TTM: four quarters to 30 Sep 2026 (consolidated). Balance sheet 30 Sep 2026. Industry P/E is the median of 21 Pharmaceuticals & Biotechnology stocks.
Quarterly results
| Growth | 1Y | 3Y CAGR |
|---|---|---|
| Revenue | +26.74% | +10.72% |
| Net profit | — | — |
Trailing twelve months against the same period 1 and 3 years earlier (3Y as a yearly rate); consolidated.
| Quarter | Revenue | Net profit | YoY profit | EPS |
|---|---|---|---|---|
| Sep 2026 | ₹980 Cr | ₹73 Cr | −10.98% | ₹4.85 |
| Jun 2026 | ₹960 Cr | ₹107 Cr | — | ₹6.55 |
| Mar 2026 | ₹1,010 Cr | ₹164 Cr | — | ₹10.22 |
| Dec 2025 | ₹913 Cr | ₹61 Cr | +205.00% | ₹3.61 |
| Sep 2025 | ₹803 Cr | ₹82 Cr | — | ₹4.81 |
| Jun 2025 | ₹758 Cr | −₹108 Cr | — | −₹5.53 |
| Mar 2025 | ₹758 Cr | −₹45 Cr | — | −₹1.57 |
| Dec 2024 | ₹729 Cr | ₹20 Cr | — | ₹0.91 |
Armor risk check
WOCKHARDT moves about 3× as much as the market
Volatility, past year
Worst fall, past year
Compared with the Nifty 500 over the past 12 months.
Check it against your portfolio in the appFAQs
What is WOCKHARDT's share price today?
WOCKHARDT (NSE: WOCKPHARMA) closed at ₹2,054.00 on 12 Nov 2026, up 0.95% from the previous close of ₹2,034.60. It traded between ₹2,025.00 and ₹2,064.00 that day.
What are WOCKHARDT's 52-week high and low?
Over the last 52 weeks WOCKHARDT traded between ₹1,086.70 and ₹2,422.30, adjusted for splits and bonuses.
What are WOCKHARDT's NSE symbol, BSE code and ISIN?
WOCKHARDT has NSE symbol WOCKPHARMA, BSE code 532300, ISIN INE049B01025.
How has WOCKHARDT performed over 1, 3 and 5 years?
WOCKHARDT's share price return: 1Y +51.01%, 3Y +101.65% a year, 5Y +37.59% a year. Dividends are not included.
Does WOCKHARDT pay a dividend?
Yes. WOCKHARDT's latest dividend went ex on 17 Nov 2016: Interim · ₹10.00 per share.
What is WOCKHARDT's P/E ratio?
WOCKHARDT's P/E ratio is 81.4: the ₹2,054.00 close on 12 Nov 2026 over trailing twelve-month EPS of ₹25.23 (consolidated, four quarters to 30 Sep 2026).
What is WOCKHARDT's market cap?
WOCKHARDT's market cap is ₹33,376 Cr at the close on 12 Nov 2026.
Which sector is WOCKHARDT in?
WOCKHARDT is in NSE's Healthcare sector, in the Pharmaceuticals & Biotechnology industry (Pharmaceuticals).
For information only. Not investment advice or a research report. Past performance does not guarantee future returns.
Full disclaimerSee how WOCKHARDT fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app